105 related articles for article (PubMed ID: 11074353)
1. Antiestrogenic effect of opioid peptides in rat uterus.
Oszter A; Vértes Z; Töröcsik B; Környei JL; Kovács KA; Vértes M
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):25-32. PubMed ID: 11074353
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of AP-1 DNA binding activity in rat hypothalamus and pituitary by estrogen.
Zhu YS; Pfaff DW
Brain Res Mol Brain Res; 1998 Mar; 55(1):115-25. PubMed ID: 9645966
[TBL] [Abstract][Full Text] [Related]
3. Effect of estradiol on expression and activation of Akt protein in rat hypothalamus exposed to chronic [D-Met2, Pro5]-enkephalinamide treatment.
Vértes Z; Lengyel F; Oszter A; Környei JL; Sumegi B; Vértes M
Steroids; 2004 Apr; 69(4):263-70. PubMed ID: 15183692
[TBL] [Abstract][Full Text] [Related]
4. Regulation of activator protein-1-DNA binding activity by opioid peptides in estrogen-sensitive cells of rat hypothalamus and uterus.
Oszter A; Törocsik B; Vértes Z; Környei JL; Kovács KA; Vértes M
Eur J Pharmacol; 2000 Apr; 395(2):103-6. PubMed ID: 10794814
[TBL] [Abstract][Full Text] [Related]
5. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
6. Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.
Környei JL; Vértes Z; Kovács KA; Göcze PM; Vértes M
Cell Prolif; 2003 Jun; 36(3):151-63. PubMed ID: 12814431
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor influenced by opioid peptides in immature rat uterus.
Vértes Z; Sándor A; Kovács KA; Oszter A; Környei JL; Kovács S; Vértes M
J Endocrinol Invest; 2000 Sep; 23(8):502-8. PubMed ID: 11021765
[TBL] [Abstract][Full Text] [Related]
8. Modulation of AP-1 mediated estrogenic response by ormeloxifene in rat uterus.
Awasthi S; Daverey A; Dwivedi A
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):208-14. PubMed ID: 17553677
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.
Petz LN; Ziegler YS; Loven MA; Nardulli AM
Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585
[TBL] [Abstract][Full Text] [Related]
10. Opioids regulate cell proliferation in the developing rat uterus: effects during the period of sexual maturation.
Vértes Z; Környei JL; Kovács S; Vértes M
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):173-8. PubMed ID: 9010332
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oestradiol-induced DNA synthesis by opioid peptides in the rat uterus.
Ordög T; Vértes Z; Vértes M
Life Sci; 1992; 51(15):1187-96. PubMed ID: 1528088
[TBL] [Abstract][Full Text] [Related]
12. In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3'-flanking region of the murine c-fos protooncogene.
Hyder SM; Stancel GM
J Steroid Biochem Mol Biol; 1994 Jan; 48(1):69-79. PubMed ID: 8136308
[TBL] [Abstract][Full Text] [Related]
13. Changes in rat uterine estrogen receptor messenger ribonucleic acid levels during estrogen- and progesterone-induced estrogen receptor depletion and subsequent replenishment.
Rosser M; Chorich L; Howard E; Zamorano P; Mahesh VB
Biol Reprod; 1993 Jan; 48(1):89-98. PubMed ID: 8418920
[TBL] [Abstract][Full Text] [Related]
14. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
Zhou JL; Brodie A
J Steroid Biochem Mol Biol; 1995 Jan; 52(1):71-6. PubMed ID: 7857875
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen decreases the estradiol induced progesterone receptors by interfering with nuclear estrogen receptor accumulation.
Castellano-Díaz E; González-Quijano MI; Limiñana JM; Díaz-Chico BN
J Steroid Biochem; 1989 Jul; 33(1):133-9. PubMed ID: 2761261
[TBL] [Abstract][Full Text] [Related]
16. The effect of 6-nitro-1,3,8-trichlorodibenzofuran as a partial estrogen in the female rat uterus.
Dickerson R; Howie L; Safe S
Toxicol Appl Pharmacol; 1992 Mar; 113(1):55-63. PubMed ID: 1313194
[TBL] [Abstract][Full Text] [Related]
17. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
[TBL] [Abstract][Full Text] [Related]
19. Estradiol up-regulates estrogen receptor and progesterone receptor gene expression in specific ovine uterine cells.
Ing NH; Tornesi MB
Biol Reprod; 1997 May; 56(5):1205-15. PubMed ID: 9160720
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
Uht RM; Anderson CM; Webb P; Kushner PJ
Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
